Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-033480)

Filing Details

Accession Number:: 0001104659-20-033480
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-13 20:49:50
Reporting Period:: 2020-03-13

Accepted Time:: 2020-03-13 20:49:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1765695	Christopher Young	C/O Akorn, Inc. 1925 West Field Court, Suite 300 Lake Forest IL 60045	Evp, Global Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-03-13	54,629	$0.56	69,273	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold at $0.5550 per share.
The amount of shares beneficially owned consists of 69,273 unvested Restricted Stock Units (RSUs).